NVNO Stock Analysis: Buy, Sell, or Hold?
NVNO - enVVeno Medical Corporation Common Stock
$10.75
-0.49 (-4.36%)
âŧ
5d:
+4.47%
30d:
+1.17%
90d:
-3.15%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When NVNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NVNO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NVNO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NVNO is currently trading at $10.75, which is considered fair relative to its 30-day fair value range of $10.26 to $11.11.
Technical Outlook: Technically, NVNO is in a downtrend. Immediate support is located at $10.13, while resistance sits at $12.49. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NVNO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+179.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVNO is in a downtrend. Immediate support is located at $10.13, while resistance sits at $12.49. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NVNO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+179.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.26 -
$11.11
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 179.1% below Wall St target ($30.00)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.26 -
$11.11
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.13
Resistance Level
$12.49
Current Trend
Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.73
Wall Street Target
$30.00
(+179.1%)
Share & Embed Analysis
Last updated: August 29, 2026 4:58 PM ET
Data refreshes hourly during market hours. Next update: 5:58 PM
Data refreshes hourly during market hours. Next update: 5:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis Duhay
SELL
140 shares
2026-03-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 48 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 43 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
